Related content

Cost analysis and quality of life assessment comparing patients undergoing autologous peripheral blood stem cell transplantation or autologous bone marrow transplantation for refractory or relapsed non-Hodgkin's lymphoma or Hodgkin's disease - a prospective randomised trial

By van Agthoven M.   Vellenga E.   Fibbe W.E.   Kingma T.   Uyl-de Groot C.A.  

European Journal of Cancer, Vol. 37, Iss. 14, 2001-09 ,pp. : 1781-1789

Elsevier

Access to resources Recommend Favorite

Autologous peripheral blood stem cell transplantation in children and adolescents with nonHodgkin lymphoma

By Gui Wei   Su Liping   He Jianxia   Wang Lieyang   Guan Tao  

Oncology Letters, Vol. 10, Iss. 3, 2015-09 ,pp. : 1826-1830

Spandidos Publications

Access to resources Recommend Favorite

Primary breast T-cell lymphoma, unspecified, treated with autologous peripheral blood stem cell transplantation: A case report and literature review

By          

Oncology Letters, Vol. 7, Iss. 1, 2014-01 ,pp. : 156-158

Spandidos Publications

Access to resources Recommend Favorite

Epstein-Barr virus-associated lymphoproliferative disorder developed following autologous peripheral blood stem cell transplantation for relapsing Hodgkin's lymphoma

By          

Oncology Letters, Vol. 3, Iss. 6, 2012-01 ,pp. : 1203-1206

Spandidos Publications

Access to resources Recommend Favorite

High-dose chemotherapy combined with autologous peripheral blood stem cell transplantation in children with advanced malignant solid tumors: A retrospective analysis of 38 cases

By                  

Oncology Letters, Vol. 10, Iss. 2, 2015-01 ,pp. : 1047-1053

Spandidos Publications

Access to resources Recommend Favorite